| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19c7b0b3ae25cc8fffd997da80cfd7f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5446f4772bca986f8dd8b21905f4e58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_acb2036f3b1e2e4abfc9a33a5b716f20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2004-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dc0b14578e2a7830edf9fe08a8ef885
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d330bf0958448f90816a31644704efb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_883ec39da872407960ae0adbe9b4579f |
| publicationDate |
2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005037222-A2 |
| titleOfInvention |
Recombinant intracellular pathogen immunogenic compositions and methods for use |
| abstract |
Immunogenic compositions comprising recombinant attenuated intracellular pathogens that have been transformed to express recombinant immunogenic antigens of the same or other intracellular pathogens are provided. Exemplary immunogenic compositions include, but are not limited to attenuated recombinant Mycobacteria expressing the major extracellular non-fusion proteins of Mycobacteria and/or other intracellular pathogens. Other embodiments are provided wherein the recombinant attenuated intracellular pathogen is auxotrophic. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012156169-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8287879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8163294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007121193-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383132-B2 |
| priorityDate |
2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |